Molecular analysis of a family of cyclin‐dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non‐small cell lung cancers

Molecular Carcinogenesis

Volumn 14, Issue 4, 1995, Pages 263-268

  Kawamata, Norihiko ^a   Miller, Carl W ^a   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

1p32; 9p21; homozygous deletion; Polymerase chain reaction single strand polymorphism analysis

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE;

ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL;

BASE SEQUENCE; BLOTTING, SOUTHERN; CARCINOMA, NON-SMALL-CELL LUNG; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P18; ENZYME INHIBITORS; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN KINASE INHIBITORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0029550322     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.2940140406     Document Type: Article

References (37)

1. p53: A frequent target for genetic abnormalities in lung cancer
2. myc family gene abnormality in lung cancers and its relation to xenotransplantability
3. Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes
4. Cyclin D1 overexpression vs. retinoblastoma inactivation: Implications for growth control evasion in non‐small cell and small cell lung cancer
5. Amplification and enhanced expression of cellular oncogene c‐Ki‐ras‐2 in a human epidermoid carcinoma of the lung
6. Cytogenetic analysis of 63 non‐small cell lung carcinomas: Recurrent chromosome alterations amid frequent and widespread genomic upheaval
7. Deletions of interferon genes in acute lymphoblastic leukemia
8. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas
9. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers
10. A cell cycle regulator potentially involved in genesis of many tumor types
11. A new regulatory motif in cellcycle control causing specific inhibition of cyclin D/CDK4
12. Mammalian G1 cyclins
13. INK4
14. Deletions of the cyclin‐dependent kinase‐4 inhibitor gene in multiple human cancers
15. p16 gene in uncultured tumors
16. Rates of p16(MTS1) mutations in primary tumors with 9p loss
17. INK4B is a potential effector of TGF‐β‐induced cell cycle arrest
18. Deletion of p16 and p15 genes in brain tumors
19. INK4B/MTS2 related CDK6 inhibitor, correlates with wild‐type pRb function
20. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D‐dependent kinases CDK4 and CDK6
21. INK4 in human cancer
22. Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK41 (cyclin‐dependent kinase‐4 inhibitor) gene in human primary non‐small cell lung carcinomas
23. In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in nonsmall cell lung cancers
24. Molecular analysis of the cyclin‐dependent kinase inhibitor gene, p27/Kip1 in human malignancies
25. Absence of WAF1 mutations in a variety of human malignancies
26. Abnormalities of PIG‐A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria
27. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia
28. klp1, a cyclin‐dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
29. Refinement of localization of the human genes for myeloperoxidase (a), protein kinase C, alpha polypeptide, PRKCA, and the DNA fragment D17S21 on chromosome 17q
30. Kip1, to regions involved in human cancer
31. Kip1: Chromosomal mapping to 12p12‐12p13.1 and absence of mutations in human tumors
32. kip1 gene to 12p13 and its analysis in leukemias
33. INK4B/MTS2, and p18 genes in primary and metastatic lung cancer
34. INK4B/IMTS2 in human leukemias and lymphomas